Abstract
This present study evaluated the salivary arginase activity (SAA) in patients with chronic periodontitis and the effect of periodontal therapy on the activity of such enzyme. Thirty-six patients (mean age, 45.97 ± 14.52), 18 chronic periodontitis subjects (test group), and 18 periodontally healthy individuals (control group) participated in the study. Clinical periodontal examinations included measurements of probing pocket depth (PD), clinical attachment level (CAL), plaque (PI), and gingival (GI) indexes. The test group received periodontal therapy according to individual needs. The saliva sample was collected from all study population at baseline (both groups) and 30 days after periodontal therapy (test group). SAA was determined by measuring the l-ornithine formation from l-arginine and was expressed as mU/ml. The results showed that the mean values of SAA were statistically different between control and test groups. SAA was about 2.5 times higher in test than control groups. Thirty days after periodontal therapy, enzyme levels were 1.56 times lower than before periodontal therapy. We concluded that SAA is increased in chronic periodontitis subjects when compared to periodontally healthy individuals and that periodontal therapy significantly reduced SAA levels. It was suggested that in the near future, SAA may be used as a salivary marker of periodontal status.
Similar content being viewed by others
References
Ainamo J, Bay I (1975) Problems and proposals for recording gingivitis and plaque. Int Dent J 25:229–235
Akopov SE, Kankanian AP (1996) Nitric oxide (NO) inactivation by polymorphonuclear leukocytes as mechanism for the development of periodontal disease. Stomatologgia 75:12–14
Aurer A, Stavljenic-Rukavina A, Aurer-Kozelj J (2005) Markers of periodontal destruction in saliva of periodontitis. Acta Med Croatica 59:117–122
Chinard FP (1952) Photometric estimation of proline and ornithine. J. Biol. Chem 199:91–95
Currie GA (1979) Activated macrophages kill tumour cells by releasing arginase. Nature 273:758–759
Debats IBJG, Booi D, Deutz NEP, Buurman WA, Boeckx WD, van der Hulst RRWJ (2006) Infected chronic wounds show different local and systemic arginine conversion compared with acute wounds. J Surg Res 134:205–214
Farram E, Nelson DS (1980) Metabolism of mouse macrophages as antitumor effector cells: role of arginase. Cell Immunol 55:283–293
Gopalakrishna R, Nagarajan B (1978) Arginase in saliva. Indian J Biochem Biophys 15:488–490
Gullu C, Özmeric N, Tokman B, Elgün S, Balos K (2005) Effectiveness of scaling and root planning versus modified Widman flap on nitric oxide synthase and arginase activity in patients with chronic periodontitis. J Periodontal Res 40:168–175
Guoyao WU, Morris SM (1998) Arginine metabolism: nitric oxide and beyond. J Biochem 336:1–17
Henskens YM, van der Weijden FA, van der Keijbus PA, Veerman EC, Timmerman MF, van der Velden U, Amerogen AV (1996) Effect of periodontal treatment on the protein composition of whole and parotid saliva. J Periodontol 67:205–212
Jeffcoat MK, Reddy MS (1991) Progression of probing attachment loss in adult periodontitis. J Periodontol 62:185–189
Jenkinson CP, Grody WW, Cederbaum SD (1996) Comparative properties of arginases. Comp Biochem Physiol 114B:107–132
Kaufman E, Lamster IB (2000) Analysis of saliva for periodontal diagnosis: A review. J Clin Periodontol 27:453–465
Kendall HK, Marshall RI, Bartold PM (2001) Nitric Oxide and tissue destruction. Oral Disease 7:2–10
Khramov VA (1997) The utilization of amino acids and urea by human oral fluid. Stomatologia 76:13–15
Konarska L, Tomaszewski L, Colombo J, Terheggen HG (1985) Human salivary arginase and its deficiency in argininaemia. J Clin Chem Clin Biochem 23:337–342
Kossel A, Dakin HD (1904) Uber die arginase. Z Physiol Chemie 41:321–331
Kroncke K, Fehsel K, Kolb-Bachofen V (1997) Nitric oxide: cytotoxicity versus citoprotection—how, when and where. Nitric Oxide Biol Chem 1:107–120
Lamster IB, Novak MJ (1992) Host mediators in gingival crevicular fluid: implications for pathogenis of periodontal disease. Crit Rev Oral Biol Med 3:31–60
Löe H, Anerud A, Boysen H, Morrison E (1986) Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 16 years of age. J Clin Periodontol 13:431–440
López NJ, Smith PC, Gutierrez J (2002) Higher risk of preterm and low birth weight in women with periodontal disease. J Dent Res 81:58–63
Mandel ID (1991) Markers of periodontal disease susceptibility and activity derived from saliva. In: Johnson NW (ed) Risk markers of diseases. Periodontal diseases: markers of disease susceptibility and activity. vol. 3. Cambridge University Press, Cambridge, pp 228–253
Miller CS, King CP Jr, Langub MC, Kryscio RJ, Thomas MV (2006) Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 137:322–329
Nathan C (1997) Inducible nitric oxide synthase: what difference does it make. J Clin Invest 100:2417–2423
Ozmeriç N, Elgun S, Uraz A (2000) Salivary arginase in patients with adult periodontits. Clin Oral Investig 4:21–24
Page RC, Schroeder HE (1976) Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 33:235–249
Polson AM, Goodson JM (1985) Periodontal diagnosis—current status and future need. J Periodontol 56:25–34
Sahingur SE, Cohen RE (2004) Analysis of host response and risk for disease progression. Periodontol 2000 34:57–83
Schneider E, Dy M (1985) The role of arginase in the immune response. Immunol Today 6:136–140
Sosroseno W, Musa M, Ravichancran M, Fikri Ibrahim M, Bird PS, Seymour GJ (2006) Arginase activity in a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 21:145–150
Uematsu H, Sato N, Hossain MZ, Ikeda T, Hoshino E (2003) Degradation of arginine and other amino acids by butyrate-producing asaccharolytic anaerobic Gram-positive rods in periodontal pockets. Arch Oral Biology 48:423–429
Ugar-Çankal D, Ozmeric N (2006) A multifaceted molecule, nitric oxide in oral and periodontal diseases. Clin Chim Acta 366:90–100
Acknowledgements
The authors are extremely grateful to the technicians at the Biochemistry Research Laboratory, Department of Biology, University of Taubaté, São Paulo, Brazil.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gheren, L.W., Cortelli, J.R., Rodrigues, E. et al. Periodontal therapy reduces arginase activity in saliva of patients with chronic periodontitis. Clin Oral Invest 12, 67–72 (2008). https://doi.org/10.1007/s00784-007-0146-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-007-0146-8